Intrepid Family Office »

Iovance Biotherapeutics shares owned by Intrepid Family Office

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Intrepid Family Office from 13F filings

Historical chart of Intrepid Family Office investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Intrepid Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Intrepid Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $87k 40k 2.17
2025-06-30 $43k 25k 1.72
2025-03-31 $133k 40k 3.33
2024-12-31 $222k 30k 7.40

More positions owned by Intrepid Family Office

Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Abrdn Platinum Etf Trust Physcl Platm Shs (PPLT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Adams Express Company (ADX)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Abrdn Silver Etf Trust Physcl Silvr Shs (SIVR)
Solar Cap (SLRC)
Listed Fds Tr Horizon Kinetics (INFL)
Shell Spon Ads (SHEL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Petroleum & Res Corp Com cef (PEO)
Nice Sponsored Adr (NICE)
Ishares Tr Msci India Etf (INDA)

View all positions for Intrepid Family Office

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics